Home LiteratureArticle Details
PMID: 21240276 Published · ppublish English

Disruption of mouse Slx4, a regulator of structure-specific nucleases, phenocopies Fanconi anemia.

Nature genetics ·Vol. 43 ·No. 2 ·2011-03-31

Crossan Gerry P, van der Weyden Louise, Rosado Ivan V, Langevin Frederic, Gaillard Pierre-Henri L, McIntyre Rebecca E, , Gallagher Ferdia, Kettunen Mikko I, Lewis David Y, Brindle Kevin, Arends Mark J, Adams David J, Patel Ketan J

Abstract

The evolutionarily conserved SLX4 protein, a key regulator of nucleases, is critical for DNA damage response. SLX4 nuclease complexes mediate repair during replication and can also resolve Holliday junctions formed during homologous recombination. Here we describe the phenotype of the Btbd12 knockout mouse, the mouse ortholog of SLX4, which recapitulates many key features of the human genetic illness Fanconi anemia. Btbd12-deficient animals are born at sub-Mendelian ratios, have greatly reduced fertility, are developmentally compromised and are prone to blood cytopenias. Btbd12(-/-) cells prematurely senesce, spontaneously accumulate damaged chromosomes and are particularly sensitive to DNA crosslinking agents. Genetic complementation reveals a crucial requirement for Btbd12 (also known as Slx4) to interact with the structure-specific endonuclease Xpf-Ercc1 to promote crosslink repair. The Btbd12 knockout mouse therefore establishes a disease model for Fanconi anemia and genetically links a regulator of nuclease incision complexes to the Fanconi anemia DNA crosslink repair pathway.

Article Info
Journal
Nature genetics
Abbr.
Nat Genet
Published
2011-03-31
Indexed
2011-01-28
Updated
2016-11-22
Language
English
Country/Region
United States
NLM ID
9216904
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com